Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Influence of molecular size on the retention of polymeric nanocarrier diagnostic agents in breast ducts.

Singh Y, Gao D, Gu Z, Li S, Rivera KA, Stein S, Love S, Sinko PJ.

Pharm Res. 2012 Sep;29(9):2377-88. doi: 10.1007/s11095-012-0763-z. Epub 2012 May 9.

2.

Noninvasive detection of passively targeted poly(ethylene glycol) nanocarriers in tumors.

Singh Y, Gao D, Gu Z, Li S, Stein S, Sinko PJ.

Mol Pharm. 2012 Jan 1;9(1):144-55. doi: 10.1021/mp2003913. Epub 2011 Nov 22.

4.

Effect of folate-targeted nanoparticle size on their rates of penetration into solid tumors.

Vlashi E, Kelderhouse LE, Sturgis JE, Low PS.

ACS Nano. 2013 Oct 22;7(10):8573-82. doi: 10.1021/nn402644g. Epub 2013 Sep 17.

PMID:
24020507
5.

Absorption of polyethylene glycol (PEG) polymers: the effect of PEG size on permeability.

Gursahani H, Riggs-Sauthier J, Pfeiffer J, Lechuga-Ballesteros D, Fishburn CS.

J Pharm Sci. 2009 Aug;98(8):2847-56. doi: 10.1002/jps.21635.

PMID:
19408293
6.

Cholesterol-poly(ethylene) glycol nanocarriers for the transscleral delivery of sirolimus.

Elsaid N, Somavarapu S, Jackson TL.

Exp Eye Res. 2014 Apr;121:121-9. doi: 10.1016/j.exer.2014.02.001. Epub 2014 Feb 13.

PMID:
24530465
7.
8.

PEGylation alleviates the non-specific toxicities of Alpha-Momorcharin and preserves its antitumor efficacy in vivo.

Deng NH, Wang L, He QC, Zheng JC, Meng Y, Meng YF, Zhang CJ, Shen FB.

Drug Deliv. 2016;23(1):95-100. doi: 10.3109/10717544.2014.905652. Epub 2014 Apr 30.

PMID:
24786488
9.

Long-circulating delivery of bioactive polysaccharide from radix ophiopogonis by PEGylation.

Lin X, Wang ZJ, Huang F, Liang S, Shen L, Feng Y, Ruan KF.

Int J Nanomedicine. 2011;6:2865-72. doi: 10.2147/IJN.S26306. Epub 2011 Nov 11.

10.

PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.

Li Y, Pei Y, Zhang X, Gu Z, Zhou Z, Yuan W, Zhou J, Zhu J, Gao X.

J Control Release. 2001 Apr 2;71(2):203-11.

PMID:
11274752
11.

[Pharmacokinetics of PEG recombinant human interleukin-6 in rats].

He XL, Yang G, Yin HL, Zhang XM.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 Jan;40(1):149-52. Chinese.

PMID:
19292067
12.

Effects of block copolymer properties on nanocarrier protection from in vivo clearance.

D'Addio SM, Saad W, Ansell SM, Squiers JJ, Adamson DH, Herrera-Alonso M, Wohl AR, Hoye TR, Macosko CW, Mayer LD, Vauthier C, Prud'homme RK.

J Control Release. 2012 Aug 20;162(1):208-17. doi: 10.1016/j.jconrel.2012.06.020. Epub 2012 Jun 23.

13.

Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.

Fu Y, Raatschen HJ, Nitecki DE, Wendland MF, Novikov V, Fournier LS, Cyran C, Rogut V, Shames DM, Brasch RC.

Biomacromolecules. 2007 May;8(5):1519-29. Epub 2007 Apr 3.

PMID:
17402781
14.

Skin Transport of Hydrophilic Compound-Loaded PEGylated Lipid Nanocarriers: Comparative Study of Liposomes, Niosomes, and Solid Lipid Nanoparticles.

Rangsimawong W, Opanasopit P, Rojanarata T, Duangjit S, Ngawhirunpat T.

Biol Pharm Bull. 2016;39(8):1254-62. doi: 10.1248/bpb.b15-00981.

15.

Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)-b-poly(DL-lactic acid) micelle nanocarriers: characterization and effects on pharmacokinetics in rat serum and urine.

Mohamed EA, Zhao Y, Meshali MM, Remsberg CM, Borg TM, Foda AM, Takemoto JK, Sayre CL, Martinez SE, Davies NM, Forrest ML.

J Pharm Sci. 2012 Oct;101(10):3787-98. doi: 10.1002/jps.23265. Epub 2012 Jul 17.

16.

The influence of polymer topology on pharmacokinetics: differences between cyclic and linear PEGylated poly(acrylic acid) comb polymers.

Chen B, Jerger K, Fr├ęchet JM, Szoka FC Jr.

J Control Release. 2009 Dec 16;140(3):203-9. doi: 10.1016/j.jconrel.2009.05.021. Epub 2009 May 22.

17.

Poly(ethylene glycol) (PEG)-lactic acid nanocarrier-based degradable hydrogels for restoring the vaginal microenvironment.

Sundara Rajan S, Turovskiy Y, Singh Y, Chikindas ML, Sinko PJ.

J Control Release. 2014 Nov 28;194:301-9. doi: 10.1016/j.jconrel.2014.08.031. Epub 2014 Sep 16.

18.

Comparative effects of PEG-containing liposomal formulations on in vivo pharmacokinetics of streptokinase.

Jin SE, Kim IS, Kim CK.

Arch Pharm Res. 2015 Oct;38(10):1822-9. doi: 10.1007/s12272-015-0594-7. Epub 2015 Apr 8.

PMID:
25851624
19.

Enhanced Antitumor Efficacy and Reduced Toxicity of Docetaxel Loaded Estradiol Functionalized Stealth Polymeric Nanoparticles.

Jain S, Spandana G, Agrawal AK, Kushwah V, Thanki K.

Mol Pharm. 2015 Nov 2;12(11):3871-84. doi: 10.1021/acs.molpharmaceut.5b00281. Epub 2015 Oct 1.

PMID:
26375023
20.

PEGylated inulin as long-circulating pharmaceutical carrier.

Sun G, Lin X, Wang Z, Feng Y, Xu D, Shen L.

J Biomater Sci Polym Ed. 2011;22(4-6):429-41. doi: 10.1163/092050610X487729. Epub 2010 Jun 21.

PMID:
20566038

Supplemental Content

Support Center